These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. AIDS, hepatitis and hemophilia. Lee CA J Thromb Haemost; 2004 Mar; 2(3):518-9. PubMed ID: 15009474 [No Abstract] [Full Text] [Related]
8. Hemophilia treatment in historical perspective: a review of medical and social developments. Rosendaal FR; Smit C; Briƫt E Ann Hematol; 1991 Feb; 62(1):5-15. PubMed ID: 1903310 [No Abstract] [Full Text] [Related]
9. Safety of therapeutic products used for hemophilia patients. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1988 Jul; 37(29):441-4, 449-50. PubMed ID: 3134602 [No Abstract] [Full Text] [Related]
10. Leads from the MMWR. Safety of therapeutic products used for hemophilia patients. JAMA; 1988 Aug; 260(7):901-3. PubMed ID: 3398188 [No Abstract] [Full Text] [Related]
11. Infected blood inquiry in the UK. Burki T Lancet Infect Dis; 2021 Aug; 21(8):1078-1079. PubMed ID: 34331882 [No Abstract] [Full Text] [Related]
16. AIDS and hemophilia: a cruel paradox. Fisher DW Hosp Pract (Off Ed); 1987 Apr; 22(4):15. PubMed ID: 3104358 [No Abstract] [Full Text] [Related]
17. Impact of AIDS on blood services in the United States. Sandler SG; Katz AJ Vox Sang; 1984; 46(1):1-7. PubMed ID: 6702138 [No Abstract] [Full Text] [Related]
18. Acquired immunodeficiency syndrome (AIDS) and blood products. Miller RD; Bove JR Anesthesiology; 1983 Jun; 58(6):493-4. PubMed ID: 6859578 [No Abstract] [Full Text] [Related]
19. The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy. Pierce GF; Lusher JM; Brownstein AP; Goldsmith JC; Kessler CM JAMA; 1989 Jun; 261(23):3434-8. PubMed ID: 2498537 [TBL] [Abstract][Full Text] [Related]